These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 11043840

  • 1. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T, Szmigielska A.
    Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
    [Abstract] [Full Text] [Related]

  • 2. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J, Robak T.
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [Abstract] [Full Text] [Related]

  • 3. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Marañda E, Szmigielska A, Robak T.
    Cancer Invest; 1999; 17(2):95-101. PubMed ID: 10071592
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic effect of cyclosporin A alone and in combination with 2-chlorodeoxyadenosine against P388 murine leukemia in vivo.
    Józefowicz-Okonkwo G, Szmigielska-Kapłon A, Robak T.
    Med Sci Monit; 2002 Sep; 8(9):BR373-7. PubMed ID: 12218939
    [Abstract] [Full Text] [Related]

  • 5. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
    Szmigielska-Kaplon A, Ciesielska E, Szmigiero L, Robak T.
    Eur J Haematol; 2002 Jun; 68(6):370-5. PubMed ID: 12225395
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
    Potemski P, Polakowski P.
    Arch Immunol Ther Exp (Warsz); 1997 Jun; 45(2-3):249-53. PubMed ID: 9597095
    [Abstract] [Full Text] [Related]

  • 9. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM, Katato K, Almatchy VP, Wall N, Liu KZ, Schultz CP, Mantsch HH, Varterasian M, al-Katib AM.
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A, Smolewski P, Najder M, Robak T.
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
    Wrzesień-Kuś A, Robak T, Wierzbowska A, Lech-Marańda E, Pluta A, Wawrzyniak E, Krawczyńska A, Kuliczkowski K, Mazur G, Kiebiński M, Dmoszyńska A, Wach M, Hellmann A, Baran W, Hołowiecki J, Kyrcz-Krzemień S, Grosicki S, Polish Adult Leukemia Group.
    Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
    [Abstract] [Full Text] [Related]

  • 13. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
    Warzocha K, Robak T.
    Acta Haematol Pol; 1992 Sep; 23(1):55-62. PubMed ID: 1615753
    [Abstract] [Full Text] [Related]

  • 14. Effects of Dex-Verapamil on Doxorubicin cytotoxicity in P388 murine leukemia cells.
    Noviello E, Allievi E, Russo P, Parodi S.
    Anticancer Drug Des; 1997 Jun; 12(4):261-76. PubMed ID: 9199659
    [Abstract] [Full Text] [Related]

  • 15. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A, Robak T.
    Arch Immunol Ther Exp (Warsz); 2003 Jun; 51(1):61-7. PubMed ID: 12691305
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L, Rauko P, Liska J, Elford HL, Szekeres T.
    Cancer Lett; 2006 Feb 20; 233(1):178-84. PubMed ID: 15885888
    [Abstract] [Full Text] [Related]

  • 17. Lack of dexamethasone effect on the antitumor activity of cisplatin.
    Aapro MS, Alberts DS, Serokman R.
    Cancer Treat Rep; 1983 Nov 20; 67(11):1013-7. PubMed ID: 6685569
    [Abstract] [Full Text] [Related]

  • 18. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice].
    Dai ZQ, Xu JY, Yuan XJ, Cai JC.
    Zhongguo Yao Li Xue Bao; 1996 Jan 20; 17(1):69-71. PubMed ID: 8737460
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of pyrimidinones, a class of small-molecule biological response modifiers.
    Li LH, Wallace TL, Wierenga W, Skulnick HI, DeKoning TF.
    J Biol Response Mod; 1987 Feb 20; 6(1):44-55. PubMed ID: 3559628
    [Abstract] [Full Text] [Related]

  • 20. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
    Watanabe A, Kuriyama H, Kiyota T.
    Gan To Kagaku Ryoho; 1996 Feb 20; 23(3):291-6. PubMed ID: 8712821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.